A new study suggests Vitamin B3 may help reverse fatty liver disease by targeting microRNA-93, which drives fat buildup. By ...

March 31 (Reuters) - The U.S. Food and Drug Administration on Monday said it had identified cases of liver injury in patients ...

A surprising new study reveals that blocking a supposedly protective enzyme, Caspase-2, could actually backfire—raising the risk of chronic liver damage and cancer over time. Researchers found that ...

To be boon for patients as internationally established Y-90 costs ₹10 lakh, say experts; the trial will begin at ...

While there are currently no approved perioperative treatments for liver cancer, multiple late-stage trials are evaluating ...

Amgen’s rare disease drug Tavneos is under mounting regulatory scrutiny, with the FDA warning of serious liver injuries, ...

A couple opens up about navigating cancer care, advocating for themselves and balancing caregiver responsibilities with ...

Caregiving evolved from quasi-nursing tasks and close monitoring to anticipatory scheduling, fatigue management, and ...

Researchers have identified microRNA-93 as a key genetic driver of fatty liver disease and discovered that vitamin B3 can effectively shut it down. This finding suggests a safe, widely available ...

While there are currently no approved perioperative treatments for liver cancer, multiple late-stage trials are evaluating ...

US regulators urge patients to discuss with clinicians the risks of avacopan and to consider an alternative treatment to this medicine, which is approved for a rare autoimmune disease.

Global hepatitis B treatment efforts are at a turning point. Major treatment guidelines have been updated in the past few years, including from the Chinese Society of Hepatology and Chinese Society of ...